Association of E-cadherin gene 3′-UTR C/T polymorphism with calcium oxalate stone disease

Urologia Internationalis

Volumn 70, Issue 4, 2003, Pages 278-281

  Tsai, Fuu Jen ^a   Wu, Hsi Chin ^a   Chen, Huey Yi ^a,b   Lu, Hsueh Fu ^a   Hsu, Cheng Der ^a   Chen, Wen Chi ^a,c  

^a CHINA MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^b NATIONAL TSING HUA UNIVERSITY   (Taiwan)

^c NONE   (Taiwan)

Author keywords

CDH 1 gene; E cadherin; Single nucleotide polymorphisms; Urolithiasis

Indexed keywords

CALCIUM OXALATE; UVOMORULIN;

3' UNTRANSLATED REGION; ADULT; AGED; ALLELE; ARTICLE; CALCIUM STONE; CONTROLLED STUDY; DNA POLYMORPHISM; FEMALE; GENETIC ASSOCIATION; GENETIC MARKER; GENOTYPE; HOMOZYGOTE; HUMAN; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RESTRICTION MAPPING;

ADULT; AGED; CADHERINS; CALCIUM OXALATE; FEMALE; GENETIC MARKERS; GENOTYPE; HUMANS; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; POLYMORPHISM, SINGLE NUCLEOTIDE; URINARY CALCULI;

EID: 0038639109     PISSN: 00421138     EISSN: None     Source Type: Journal    
DOI: 10.1159/000070135     Document Type: Article

References (19)

1. Finlayson B, Reid F: The expectation of free and fixed particles in urinary stone disease. Invest Urol 1978;15:442-448.
2. Kok DJ, Khan SR: Calcium oxalate nephrolithiasis, a free or fixed particle disease. Kidney Int 1994;46:847-854.
3. Hackett RL, Shevock PN, Khan SR: Cell injury associated calcium oxalate crystalluria. J Urol 1990;144:1535-1538.
4. Thamilselvan S, Byer KJ, Hackett RL, Khan SR: Free radical scavengers, catalase and superoxide dismutase provide protection from oxalate-associated injury to LLC-PK1 and MDCK cells. J Urol 2000;164:224-229.
5. Scheid C, Koul H, Hill WA, Luber-Nardo J, Kennington L, Honeyman T, Jonassen J, Me-non M: Oxalate toxicity in LLC-Pk1 cells: Role of free radicals. Kidney Int 1996;49:413-419.
6. Aberle H, Schwartz H, Kemler R: Cadherin-catenin complex: Protein interactions and their implications for cadherin function. J Cell Biochem 1996;61:514-523.
7. Shimoyama Y, Hirohashi S, Hirano S, Noguchi M, Shimosato Y, Takeichi M, Abe O: Cadherin cell-adhesion molecules in human epithelial tissues and carcinomas. Cancer Res 1989;49:2128-2133.
8. Chen WC, Chen HY, Lu HF, Hsu CD, Tsai FJ: Association of vitamin D receptor gene start codon Fok I polymorphism with calcium oxalate stone disease. Br J Urol 2001;87:168-171.
9. Chen WC, Wu HC, Lu HF, Chen HY, Tsai FJ: Calcitonin receptor gene polymorphism: A possible genetic marker for patients with calcium oxalate stones in Taiwan. Eur Urol 2001;39:716-719.
10. Becker KF, Reich U, Schott C, Hofler H: Single nucleotide polymorphisms in the human E-cadherin gene. Hum Genet 1995;96:739-740.
11. Krepinsky J, Ingram AJ, Churchill DN: Metabolic investigation of recurrent nephrolithiasis: Compliance with recommendations. Urology 2000;56:915-920.
12. Strachen T, Read AP: Genetic mapping of complex characters; in Human Molecular Genetics, ed 2. New York, Wiley, 1999, chapt 12, p 287.
13. De Water R, Noordermeer C, Houtsmuller AB, Nigg AL, Stijnen T, Schroder FH, Kok DJ: Role of macrophages in nephrolithiasis in rats: An analysis of the renal interstitium. Am J Kidney Dis 2000;36:615-625.
14. Ojakian GK, Ratcliffe DR, Schwimmer R: Integrin regulation of cell-cell adhesion during epithelial tubule formation. J Cell Sci 2001;114:941-952.
15. Krill D, Thomas A, Wu SP, Dhir R, Becich MJ: E-cadherin expression and PSA secretion in human prostate epithelial cells. Urol Res 2001;29:287-292.
16. Yap AS: The morphogenetic role of cadherin cell adhesion molecules in human cancer: A thematic review. Cancer Invest 1998;16:252-261.
17. Tsujihata M, Miyake O, Yoshimura K, Kakimoto KI, Takahara S, Okuyama A: Fibronectin as a potent inhibitor of calcium oxalate urolithiasis. J Urol 2000;164:1718-1723.
18. Pratt RE, Dzau VJ: Genomics and hypertension: Concepts, potentials and opportunities. Hypertension 1999;33:238-247.
19. Kwok PK, Gu Z: Single nucleotide polymorphism libraries: Why and how are we building them? Mol Med Today 1999;5:538-543.